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Abstract
Background: Among Coagulase-Negative Staphylococci (CoNS), Staphylococcus hominis represents the third most common
organism recoverable from the blood of immunocompromised patients. The aim of this study was to characterize biofilm
formation, antibiotic resistance, define the SCCmec (Staphylococcal Chromosomal Cassette mec) type, and genetic
relatedness of clinical S. hominis isolates.
Methodology: S. hominis blood isolates (n = 21) were screened for biofilm formation using crystal violet staining. Methicillin
resistance was evaluated using the cefoxitin disk test and the mecA gene was detected by PCR. Antibiotic resistance was
determined by the broth microdilution method. Genetic relatedness was determined by pulsed-field gel electrophoresis
(PFGE) and SCCmec typed by multiplex PCR using two different methodologies described for Staphylococcus aureus.
Results: Of the S. hominis isolates screened, 47.6% (10/21) were categorized as strong biofilm producers and 23.8% (5/21) as
weak producers. Furthermore, 81% (17/21) of the isolates were methicillin resistant and mecA gene carriers. Resistance to
ampicillin, erythromycin, and trimethoprim was observed in .70% of isolates screened. Each isolate showed a different
PFGE macrorestriction pattern with similarity ranging between 0–95%. Among mecA-positive isolates, 14 (82%) harbored a
non-typeable SCCmec type: eight isolates were not positive for any ccr complex; four contained the mec complex A ccrAB1
and ccrC, one isolate contained mec complex A, ccrAB4 and ccrC, and one isolate contained the mec complex A, ccrAB1,
ccrAB4, and ccrC. Two isolates harbored the association: mec complex A and ccrAB1. Only one strain was typeable as SCCmec
III.
Conclusions: The S. hominis isolates analyzed were variable biofilm producers had a high prevalence of methicillin
resistance and resistance to other antibiotics, and high genetic diversity. The results of this study strongly suggested that S.
hominis isolates harbor new SCCmec structural elements and might be reservoirs of ccrC1 in addition to ccrAB1 and mec
complex A.
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Introduction
Coagulase-negative staphylococci (CoNS) represent a group of
opportunistic microorganisms commonly associated with infec-
tions of immunocompromised patients [1]. Among CoNS,
Staphylococcus hominis is one of the three most frequently identified
isolates recoverable from the blood of neonates and immunosup-
pressed patients [2,3] and has been associated as a causal agent of
bacteremia, septicemia, and endocarditis [3–7]. Nosocomial
infections caused by CoNS are associated with the use of
indwelling medical devices in combination with biofilm-forming
potential of respective isolates [8–10]. However, among the CoNS,
S. hominis strains are not typically categorized as a major biofilm
producers [9,11]. It has been reported that some S. hominis isolates
are resistant to methicillin that is conferred by protein PBP2a
encoded by the mecA gene that resides within a mobile genetic
element called the Staphylococcal Cassette Chromosome mec
(SCCmec) [12]. At present, eleven SCCmec types (I–XI) of have
been assigned for S. aureus based on the classes of the mec gene
complex (A–E) and the ccr gene complex (1–8) (http://www.
sccmec.org/Pages/SCC_TypesEN.html). Some studies have re-
ported that SCCmec elements are more diverse in methicillin-
resistant CoNS, with new variants of ccr genes continually being
identified [13–20].
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A recent molecular epidemiologic study of S. hominis isolates
conducted by Bouchami et al., 2011 demonstrated low clonality
between isolates and the identification of isolates harboring the
SCCmec type VI, VIII, and the new SCCmec type composed of mec
complex A (in combination with ccrAB1). In addition, some isolates
harbored the non-typeable SCCmec in the absence of the ccr
complex and others expressed two ccr types (in the same isolate).
Additionally, ccrB1 and ccrB4 were identified in mecA-negative and
mecA-positive isolates with high nucleotide sequence homology to
genes present in S. aureus isolates expressing SCCmec I, VI, or VIII,
respectively (.95%) [21].
In agreement with a report by Hanssen et al., 2004 staphylo-
coccal strains from the same geographical region possess identical
ccr genes that differ from sequences of strains from other regions.
There is evidence of horizontal SCCmec gene transfer between
CoNS and S. aureus [22,23]; therefore, characterization of SCCmec
of S. hominis can provide useful information regarding the evolution
and mobilization of this element from this species. The aim of this
study was to characterize biofilm formation potential, antibiotic
resistance, SCCmec type, and genetic relatedness of 21 S. hominis
clinical isolates obtained from blood cultures.
Materials and Methods
Ethics Statement
This study was performed with the approval of the Local Ethics
Committee of the School of Medicine of the Universidad
Auto´noma de Nuevo Leo´n (Approval MB11-006). Informed
consent was not required since bacterial isolates were the subject
of this study. Isolates, not human beings were studied. Thus,
informed consent was not required by the local Ethics Committee.
Clinical isolates
S. hominis clinical isolates (n = 21) were collected between
January 2006 and December 2011 from blood cultures from two
hospitals in Mexico: Hospital Civil Fray Antonio Alcalde and
Hospital Universitario Dr. Jose´ Eleuterio Gonza´lez. All isolates
were causative agents of Laboratory-Confirmed Bloodstream
Infection (LCBI) according to CDC criteria (http://www.cdc.
gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf). Isolates
examined met at least one of the following criteria: a) Patient
had a recognized pathogen cultured from two or more blood
cultures and organisms cultured from blood were not related to an
infection at another site, b) Ppatient had at least one of the
following signs or symptoms: fever (.38uC), chills, or hypotension
and positive laboratory results not related to an infection at
another site. Isolates were kept frozen in Brucella broth containing
15% glycerol at 270uC. Only one isolate per patient was included
in this study.
Identification of isolates. Isolates were identified at the
species level using API Staph galleries (bioMe´rieux, Inc., Durham,
NC) according to the manufacturer’s instructions. Species
identification was confirmed by partial sequencing of the 16S
rRNA and the tuf genes as previously described [24]. Sequencing
was performed at the Instituto de Biotecnologı´a, Universidad
Nacional Auto´noma de Me´xico. DNA sequences were compared
to gene sequences at the National Center for Biotechnology
Information (NCBI) GenBank using the BLAST algorithm
(http://www.ncbi.nlm.nih.gov/BLAST).
Phenotypic biofilm assay. Semi quantitative determination
of biofilm formation was performed by crystal violet staining as
previously described [10,25]. All isolates were tested in quadru-
plicate in two different experiments conducted on different days.
These assays were conducted on polystyrene 96-well flat bottom,
untreated plates with a low evaporation lid. Biofilm-forming
capacity of all isolates was tested under two different growth
conditions: in trypticase soy broth (TSB) supplemented with 1%
glucose (TSBglu) or in TSB supplemented with 3% NaCl (TSB
NaCl). Briefly, biofilm samples stained with crystal violet were
dissolved in an ethanol–acetone mixture (70:30). The optical
density of these solutions was subsequently measured at 550 nm.
To simplify the data we used the ordinal classification for the level
of biofilm production proposed by Christensen et al. Isolates with
optical densities OD $0.25 were considered strong biofilm
producers and isolates with optical densities between 0.15 and
0.24 were considered weak biofilm producers.
Staphylococcus saprophyticus ATCC 15305 (biofilm producer) and
S. hominis ATCC 27844 (biofilm non-producer) were used as
control organisms.
Methicillin resistance and susceptibility testing. Methicillin
resistance was evaluated using the cefoxitin disk test and the mecA gene
was detected by polymerase chain reaction (PCR) [26,27]. During the
cefoxitin disk evaluation, isolates were considered resistant if measure-
ments were$24 mm and susceptible if measurements were#25 mm
[27]. Susceptibility testing was performed using the broth microdilution
method as recommended by the Clinical and Laboratory Standards
Institute (CLSI) [27]. The antibiotics tested were penicillin, ampicillin,
amoxicillin-clavulanic acid, cefotaxime, vancomycin, daptomycin,
gentamicin, erythromycin, tetracycline, ciprofloxacin, nitrofurantoin,
trimethoprim, chloramphenicol, rifampin, and linezolid (Sigma
Aldrich, Toluca, Mexico).
SCCmec and PFGE typing. SCCmec, ccr, and mec class
typing was performed as previously described by Zhang et al. [26]
and Kondo et al. [28] with modification to three primers as
previously described Ruppe et al [29]. All SCCmec typing
experiments were performed in duplicate. As control strains we
used for all PCR reactions isolates previously typed by Garza-
Gonza´lez et al., 2010: Staphylococcus epidermidis JC-5, JC-6, JC-28,
JC-30, JC-488, JC-1439 and Staphylococcus haemolyticus JC-2165
[14,30]. PFGE was performed as described for S. aureus [31] with
modifications to the restriction enzymes used and running
conditions were as previously described by Bouchami et al. [21].
S. hominis DNA samples were digested with the XhoI endonuclease
and bands were separated using a CHEF-DRIII instrument (Bio-
Rad Laboratories, Hercules, CA). Band patterns were generated
by visual analysis using Labworks 4.5 software with 1% of
tolerance. The similarity coefficients were generated from a
similarity matrix calculated using the Jaccard coefficient (SPSS
20.0 software).
Results
Biofilm formation
By assay with TBSglu, 47.6% (10/21) of the S. hominis isolates
were categorized as strong biofilm producers (defined by the cut-
off values used in this study). Weak biofilm production was
observed in 23.8% (5/21) of the isolates and 28.6% (6/21) were
non-producers. Whereas by assay with TBS NaCl, 33.3% (7/21)
were strong biofilm producers, 23.8% (5/21) weak producers, and
42.9 (9/21) non-producers (Table 1).
Methicillin resistance and susceptibility testing
Most isolates, 81% (17/21), showed methicillin resistance by the
cefoxitin disk test, and all isolates tested positive for the mecA gene
(Table 1). All S. hominis isolates were resistant to at least one of the
non-b-lactam antibiotics tested. Resistance rates for penicillin,
ampicillin, amoxicillin-clavulanic acid, erythromycin, trimetho-
prim, ciprofloxacin, tetracycline, chloramphenicol, gentamicin,
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rifampin, nitrofurantoin, and cefotaxime for all isolates were 95%,
95%, 95%, 95%, 76%, 52%, 43%, 38%, 33%, 19%, 10%, and
10%, respectively. Furthermore, 48% of isolates were daptomycin-
non susceptible. None of the 21 isolates tested in this study were
found to be resistant to vancomycin or linezolid. The 4 mecA-
negative isolates showed resistance to at least one of the b-lactam
antibiotics tested. No correlation was found between the level of
biofilm production and the resistance phenotype.
SCCmec and PFGE typing
A high frequency of mec complex class A (88.2%), ccrAB1
(41.1%), and ccrC (35.3%) was observed among mecA-positive S.
hominis isolates (Table 1).
Among the 17 mecA-positive isolates a high proportion were
non-typeable (82%), eight were negative for ccr complex tested by
both methods (UT); four isolates had a mec complex AccrAB1 and
ccrC (UT1), one isolate had the mec complex A, ccrAB4 and ccrC
(UT2), and; one isolate had the mec complex A, ccrAB1, ccrAB4 and
ccrC (UT3). Two isolates carried association mec complex A and
ccrAB1. One strain had SCCmec type III described for S. aureus
(Table 1) (mec complex A, ccr 3, and isolate 8179).
PFGE analysis of S. hominis isolates identified 21 different
restriction patterns with at least 3 band differences between each
isolate (Figure 1). Although a 100% similarity was not observed
between isolates, two isolates had 95% similarity (11630 and
11631) and were categorized as strong biofilm producers, mecA-
positive, mec class A, ccrAB1+ccrC, and only differed in their
susceptibility pattern.
Discussion
Most studies examining the presence of SCCmec among CoNS
isolates have included in their respective analyses few S. hominis
clinical isolates recovered from catheters, the catheter insertion
site, pus, wound secretions, cerebral spinal fluid, or blood
[11,13,14,21,30,32–34]. S. hominis comprises part of the normal
flora colonizing the skin and mucous membranes of humans and
may be found as a culture contaminant. However, detection of S.
hominis is indicative of an infection and a probable causative agent
of bacteremia. In this study, we analyzed 21 S. hominis clinical
isolates recovered from blood and were causative agents of
Laboratory-Confirmed Bloodstream Infection (LCBI) according to
CDC criteria. To our knowledge, this is the first report
characterizing S. hominis isolates identified as causative agents of
bacteremia recovered from the blood at the microbiological and
molecular level.
A significant observation associated with the S. hominis isolates
studied was the ability of almost half of these strains (47.6%) to
produce biofilm (since S. hominis is not known as a major biofilm
producer) [9,11]. This characteristic represents a significant
virulence factor since biofilms facilitate bacterial adherence to
biomedical surfaces (such as catheters), thereby facilitating their
entrance into the bloodstream [8]. However, the polysaccharide or
Figure 1. PFGE dendrogram of S. hominis isolates. Similarity coefficients were generated from a similarity matrix calculated with the Jaccard
coefficient using SPSS 20.0 software.
doi:10.1371/journal.pone.0061161.g001
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protein composition of S. hominis biofilms (or genes involved on its
production) remains unknown to date.
Among the mecA-positive isolates (81%), nearly half were
carriers of a putative new SCCmec. In addition, most expressed
the mec gene class A, ccr type 1, and others ccr type 5. This
combination of mec-ccr complexes has been reported in this
bacterial species before [11,14,21,32].
The mec-ccr complexes identified in this study were similar to
those reported by Bouchami et al. that demonstrated that S. hominis
could serve as a mec-ccr reservoir and also serve as a likely donor of
ccrAB1 and mec complex A to other bacterial species. Unlike that
study, we found a higher proportion of non-typeable isolates (82%)
and isolates harboring ccrC (29%).
The data regarding SCCmec diversity in CoNS presented in this
study may be biased due to the typing methodology used that was
developed for S. aureus, therefore caution should be taken in the
interpretation of these data. Therefore, a variety of non-typeable
elements in CoNS may be simply an indication that S. hominis
elements are different enough from those of S. aureus that the
present typing methods can not be applied to this CoNS.
Data presented in this report also demonstrated that most
isolates with new or untypeable SCCmec were resistant to at least
three antibiotic classes, and some isolates presented with two or
three recombinase complexes types, suggesting the presence of
multiple SCCmec elements in tandem. However, to verify this, the
S. hominis SCCmec cassette should be sequenced completely and
compared to the S. aureus cassette. This analysis is currently
underway in our laboratory.
We found that the 82% of mecA-positive isolates were untype-
able and neither of the two methods used amplified any of the
know recombinases suggesting that these strains are therefore
likely candidates for carrying novel SCCmec types. This observa-
tion was previously described for S. hominis [11,13,21,30,33,34]
and may be explained by: a) that this cassette is a carrier of a new
recombinase not related to ccrAB or ccrC genes, b) they represent
new ccr complex isotypes that cannot be amplified by currently
utilized ccr primers, or c) ccr genes were not present [23].
In this study, we identified a high rate of methicillin resistance
(81%) in addition to resistance to other antibiotics among the
clinical isolates studied; an observation previously reported for S.
hominis and other CoNS species [17,21]. All methicillin resistant
isolates were also positive for SCCmec in addition to displaying
resistance to most b-lactams antibiotics tested.
Among the S. hominis isolates collected in the present study none
were clonal, therefore we concluded that infections caused by
these isolates were not caused by dissemination of the same isolate
throughout the hospital. Taking into account the fact that S.
hominis is a component of the normal skin and mucous membrane
flora, it is likely that these infections were endogenous.
In conclusion, our results showed that S. hominis is a biofilm
producer and in combination with its high resistance rate to
antibiotics, renders this species a serious threat for infections in
immunocompromised patients. Finally, S. hominis isolates may
possess different SCCmec types compared to those present in S.
aureus.
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